Get started

Palatin Technologies, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

PTN chart

Key stats

Market capitalization
28.038MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.15USD
Net income
−27.542MUSD
Revenue
4.854MUSD
Shares float
13.711M
Beta
1.35

About Palatin Technologies, Inc.

Sector
Health Technology
CEO
Carl Spana
Headquarters
Cranbury
Website
palatin.com
Employees (FY)
34
Founded
1986
ISIN
US6960775020
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Ideas

☆ PTN possible bullish flag ☆ Enter if it breaks this flag/triangle pattern on the 15-1 hr timeframe, putting your stop loss just below the candle you enter on. Close some of your position after a few hours. Close the entire position when price closes below the 10 SMA. sorry I meant to tag this as "long" ~this is just an idea~
Long
by fluffystat
Bullish Cypher Pattern on PTN ChartThis pattern gives a first target to return to level A at about 8.10-8.20 and a second target to return to level C at around 8.50. Anticipated Catalysts for remaining 2022: NA/US Licensing Vyleesi ROW Licensing Vyleesi PL3994 PH2 Heart Failure Data Diabetic Nephropathy PH 2 Initiate Study
Long
by muhley
$PTN entry PT .70-.75 Target PT 1.59 Long term PT 5 and higher$PTN H.C. Wainwright analyst Joseph Pantginis is behind today’s news as he reiterated the firm’s buy rating for PTN stock. To go along with that, Pantginis also increased the price target for PTN stock from $2 per share to $5 per share, 1,371% upside Palatin Technologies, Inc., a biopharmaceutical
Long
by BADQOMOCAWGOWLD
Palatin Technologies 500%+ Expected ReturnCompany Profile Sector: Health Care Industry: Biotechnology Company Location: Cranbury, NJ Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a
Long
by thedailyinvestor
PTN - Movement on News, Article and YouTube VideosI just created this chart to better understand how PTN moved on the big spike recently. Seems like it didn't take much, just a Yahoo article after the positive dry eye news and then a few YouTube videos. Here are the links to the article and videos: 12/22/2020 Michael Marcus - TipRanks tipranks.c
Long
by muhley

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers